Table 1. Clinicopathological characteristics of OSCC patients evaluated for EGFR protein expression and EGFRvIII frequency.
| n = 54 | |
| Sex (n, %) | |
| Male | 38 (70%) |
| Female | 16 (30%) |
| Age (mean, sd) | 61 (12.3) |
| Smoking History (n, %) | |
| Never | 12 (22%) |
| Past | 12 (22%) |
| Current | 30 (56%) |
| Alcohol History (n,%) | |
| Never | 6 (11%) |
| Moderate | 19 (35%) |
| Heavy | 15 (28%) |
| Former Heavy | 10 (19%) |
| Not Stated | 4 (7%) |
| Pathologic T Stage (n, %) | |
| pT1 | 8 (15%) |
| pT2 | 19 (35%) |
| pT3 | 12 (22%) |
| pT4 | 15 (28%) |
| Pathologic N Stage (n, %) | |
| pN0 | 28 (52%) |
| pN1 | 7 (13%) |
| pN2 | 19 (35%) |
| Differentiation (n, %) | |
| Well | 10 (19%) |
| Moderate | 31 (57%) |
| Poor | 6 (11%) |
| Not Stated | 7 (13%) |